Telangana Today·3 min read·medium
Centre tightens checks on GLP-1 weight-loss drug promotion
P
PTI
✦AI Summary
The Indian government has ordered drug regulators to increase surveillance on the promotion and supply chain of GLP-1 weight-loss drugs. Authorities are cracking down on surrogate advertising and ensuring these medications are only used for approved medical conditions under strict supervision.
New Delhi: The Centre has directed drug regulators across states and Union Territories to tighten surveillance over the supply chain and promotion of GLP-1 weight-loss drugs amid concerns over surrogate advertising and misleading awareness campaigns.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in